Navigation Links
National Business Group on Health Awards Gold to Blue Cross and Blue Shield of Minnesota for Promoting a Healthy Workplace
Date:5/14/2008

EAGAN, Minn., May 14 /PRNewswire/ -- Blue Cross and Blue Shield of Minnesota (Blue Cross) was one of only 52 companies nationally to be recognized by the National Business Group on Health on May 12 for its efforts to promote and improve a healthier working environment as part of the Best Employers for Healthy Lifestyles awards. Blue Cross was the only health plan in Minnesota to receive the award.

The National Business Group on Health, a national nonprofit, honored and rewarded employers that offer programs to improve their worker's health, productivity and quality of life. Blue Cross was recognized in the gold category for creating cultural and environmental changes that support employees who have made a commitment to long-term behavior changes. The other Minnesota health care companies to be recognized in the gold category were General Mills and Mayo Clinic.

"At Blue Cross, we are committed to helping our employees live life well and enjoy active, healthy lifestyles," Roger Kleppe, senior vice president, human resources and facilities, said. "It's a win-win situation. Our employees feel better if they are in the best possible health and Blue Cross wins as it seeks to reduce long-term costs for chronic illnesses and to reduce productivity losses associated with preventable absenteeism and disability."

Case in point: Blue Cross offers a rebate to employees who join at-work Weight Watchers and attend 90 percent of the on-site meetings. The money for the program was well spent -- in 2007 alone, employees enrolled in the program lost a total of 1,000 pounds.

In addition, Blue Cross also offers on-site fitness centers with fitness classes, running clubs, and brown bag lunches covering a variety of health and wellness topics. Employees also have access to programs such as discounts for working out at fitness centers and worksite wellness programs. Blue Cross' "Know Your Numbers" program helps employees understand four key measures of go
'/>"/>

SOURCE Blue Cross and Blue Shield of Minnesota
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International Diabetes Federation gives grant to metabolic syndrome research project in Australia
2. Stop Obesity Alliance, Chair Dr. Richard H. Carmona, National Opinion Research Center Reveal Findings of Survey Showing Employer Concern About Health, Financial Costs of Obesity
3. SI International Awarded $11 Million Health Service Contract
4. International Society of Hair Restoration Surgery and Istituto Dermopatico dellImmacolata Host Made In Italy: Hair Restoration Live Video Surgery Workshop May 30 - June 1, 2008, Rome, Italy
5. National Business Group on Health Honors Data Recognition Corporation as One of Best Employers for Healthy Lifestyles
6. Natural Alternatives International, Inc. Announces Third Quarter Results
7. New Studies of Bush Administration $770 Million SNF Medicare Cut Find Seniors Care Jeopardized, Local Jobs Lost, National and State Economies Threatened
8. The Neuropathy Association Featured on NBCs Today Show as Part of National Neuropathy Week
9. New Presidential $1 Coin Helps Highlight National Stroke Awareness Month This May
10. A Crowning Achievement for International Pageants and Go Red For Women
11. Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 1Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 2Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 48082 3Researchers Uncover Why Turmeric Helps Heal 48078 1Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 1Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 2Chandler Chicco Companies Announces New Brandtectonics Access US Offering 48073 3